Inhibited proliferation of fibroblasts derived from chronic diabetic wounds and normal dermal fibroblasts treated with high glucose is associated with increased formation of L-lactate

Wound Repair and Regeneration

Volumn 6, Issue 2, 1998, Pages 135-141

  Hehenberger, Karin ^a   Heilborn, Johan D ^a   Brismar, Kerstin ^a   Hansson, Anders ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYBUTYRIC ACID; DNA; GLUCOSE; LACTIC ACID DERIVATIVE;

AGED; ARTICLE; CELL CULTURE; CELL DIVISION; CHRONIC DISEASE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC FOOT; DRUG EFFECT; FEMALE; FIBROBLAST; HUMAN; INJURY; MALE; METABOLISM; MIDDLE AGED; NEEDLE BIOPSY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOLOGY; PHYSIOLOGY; REFERENCE VALUE; SKIN; SPECTROPHOTOMETRY; WOUND HEALING;

3-HYDROXYBUTYRIC ACID; AGED; BIOPSY, NEEDLE; CELL DIVISION; CELLS, CULTURED; CHRONIC DISEASE; DIABETES MELLITUS, TYPE 2; DIABETIC FOOT; DNA; FEMALE; FIBROBLASTS; GLUCOSE; HUMANS; LACTATES; MALE; MIDDLE AGED; REFERENCE VALUES; SKIN; SPECTROPHOTOMETRY; WOUND HEALING;

EID: 0032010090     PISSN: 10671927     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-475X.1998.60207.x     Document Type: Article

References (29)

1. Andreassen TT, Oxlund H. The influence of experimental diabetes and insulin treatments on the biochemical properties of rat skin incisional wounds. Acta Chir Scand 1987;153:405-9.
2. Hehenberger K, Kratz G, Hansson A, Brismar K. Human chronic diabetic wounds have decreased fibroblast proliferation, which can be reversed by heparin. J Dermatol Sci 1998; 16.
3. Hehenberger K, Hansson A. High glucose induced growth factor resistance in human fibroblasts can be reversed by antioxidants and protein kinase C-inhibitors. Cell Biochem Funct 1997;15:197-209.
4. Eriksson J, Franssila-Kallunki A, Ekstrand A, Saloranta C, Widen E, Schalin C, Groop L. Early metabolic defects in persons at risk for NIDDM. N Engl J Med 1989;321:337-43.
5. Ginsberg H, Kimmerling G, Olefsky JM, Reaven GM. Demonstration of insulin resistance in untreated adult onset diabetic subjects with fasting hyperglycemia. J Clin Invest 1975;55:454-61.
6. Rossetti L, Smith D, Schulman GI, Papachristou D, DeFronzo RA. Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats. J Clin Invest 1987;79:1510-5.
7. Pillay TS, Xiao S, Olefsky JM. Glucose-induced phosphorylation of the insulin receptor: functional effects and characterization of phosphorylation sites. J Clin Invest 1996;97:613-20.
8. Kelley D, Mokan M, Veneman T. Impaired postprandial glucose utilization in non-insulin-dependent diabetes mellitus metabolism. Clin Exp 1994;43:1549-57.
9. van der Merwe TM, Eklund L, Jansson PA, Lonnroth PN. Effects of hyperglycaemia on in vivo adipose tissue metabolism studied with microdialysis in IDDM subjects. Diabetes 1994;43:866-70.
10. Lovejoy J, Newby FD, Gebhart SSP, DiGirolamo M. Insulin resistance in obesity is associated with elevated basal lactate levels and diminished lactate appearance following intravenous glucose and insulin. Metabolism 1992;1:22-7.
11. Friedman JE, Caro JF, Pories J, Azevedo JL, Dohn GL. Glucose metabolism in incubated human muscle: effect of obesity and non-insulin dependent diabetes mellitus. Metabolism 1994;8:1047-54.
12. Howard B, Mott D, Hidaka H, Fields R, Katzett H, Howard J, Bennett P. Cell culture studies of a patient with congenital lipoatrophic diabetes-normal insulin binding with alterations in intracellular glucose metabolism and insulin action. Metabolism 1981;9:845-51.
13. Rao J, Otto WR. Fluorometric DNA assay for cell growth estimation. Anal Biochem 1992;207:186-92.
14. Rutz HP, Little JB. Exogenous lactate interferes with cell-cycle control in Balb/3T3 mouse fibroblasts. Int J Radiat Oncol Biol Phys 1995;31:535-28.
15. Poole RC, Halestrap AP. Transport of lactate and other monocarboxylates across mammalian plasma membranes. Am J Physiol 1993;264:761-82.
16. Avogaro A, Toffolo G, Miola M, Valerio A, Tiengo A, Cobelli C, Del Prato S. Intracellular lactate and pyruvate interconversion rates are increased in muscle tissue of non-insulin-dependent diabetic individuals. J Clin Invest 1996;98:108-15.
17. Falanga V. Chronic wounds: pathophysiologic and experimental considerations. J Invest Dermatol 1993;100:721-5.
18. Herrick SE, Ireland GW, Simon D, McCollum CN, Ferguson MW. Venous ulcer fibroblasts compared with normal fibroblasts show differences in collagen but not fibronectin production under both normal and hypoxic conditions. J Invest Dermatol 1996;106:187-93.
19. Lombardi M, Fagrell B, Jörneskog G. Venous erythrocyte column width is increased in toe capillaries of diabetic patients [abstract]. Diabetologia 1997;587:2308.
20. Van den Enden M, Nyengaard J, Ostrow E, Burgan J, Williamson, JR. Elevated glucose levels increase retinal glycolysis and sorbitol pathway metabolism. Invest Ophthalmol Vis Sci 1995;36:1675-85.
21. Williamson JR, Chang K, Frangos M, Hasan KS, Ido Y, Kawamura T, Nyengaard J, Van den Enden M, Kilo C, Tilton RG. Hyperglycemic pseudohypoxia and diabetic complications Diabetes 1993;42:801-13.
22. Zhou YP, Grill V. Long term exposure to fatty acids and ketones inhibits B-cell functions in human pancreatic islets of Langerhans. J Clin Endocrinol Metab 1995;80:1584-90.
23. Randle PJ, Priestman DA, Mistry S, Halsall A. Mechanisms modifying glucose oxidation in diabetes mellitus. Diabetologia 1994;37:155-61.
24. Hutson NJ, Kerbey AL, Randle PJ, Sugden PH. Regulation of pyruvate dehydrogenase by insulin action. Prog Clin Biol Res 1979;31:707-19.
25. Ofenstein JP, Dandurand DM, Kiechle FL. Assessment of mitochondrial function in cells grown in tissue culture. Ann Clin Lab Sci 1992;22:406-13.
26. Kreisberg RA. Glucose-lactate interrelations in man. N Engl J Med 1973;287:132-7.
27. Henry RR, Thorburn AW, Beerdsen P, Gumbiner B. Dose-response characteristics of impaired glucose oxidation in non-insulin-dependent diabetes mellitus. Am J Physiol 1991;261:132-40.
28. Belfiore F, Iannello S. A formula for quantifying the effects of substrate cycles (futile cycles) on metabolic regulation. Its application to glucose futile cycle in liver as studied by glucose-6-phosphatase/glucokinase determinations. Acta Diabetol Lat 1990;27:71-80.
29. Kelley DE, Mokan M, Mandarino IJ. Intracellular defects in glucose metabolism in obese patients with NIDDM. Diabetes 1992;41:698-706.